Loading stock data…
Medtronic plc. (MDT)
$83.21+1.20 (+1.46%)
Market ClosedLast close Jul 24
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medtronic plc in the Healthcare sector is trading at $83.21 with a market capitalization of $106.5B. Wall Street consensus targets $97.84 (25 analysts), implying a +17.6% move over the next 12 months. The stock is currently 22% below its 52-week high of $106.33, remaining 6.5% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +17.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.81B↑ | $9.02B↑ | $8.96B↑ | $8.58B↓ | $8.93B |
| Gross Profit | $6.41B↑ | $5.76B↓ | $5.90B↑ | $5.58B↓ | $5.78B |
| Operating Income | $2.01B↑ | $1.60B↓ | $1.70B↑ | $1.52B↓ | $1.80B |
| Net Income | $1.24B↑ | $1.14B↓ | $1.37B↑ | $1.04B↓ | $1.06B |
Peer Comparison
JNJUNHPFE
Fundamentals
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Port...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$106.49B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.30
Beta
Defensive asset. Lower volatility than the S&P 500.
0.58
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.72%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.71%
Volume
Today's trading volume
3.43M
Recent News
Johnson & Johnson Is Becoming A Narrower Company Than You Bought
Management's plain health care label has slipped out of the lead, and the business now on a separation clock is the one that finally started working.
Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?
The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.
6 Medical-Device Stocks to Buy After a Massive Selloff
Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.
Medtronic Earnings Preview: What to Expect
: Medtronic is set to report Q1 earnings, with analysts expecting high single-digit year-over-year EPS growth.
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue
Intuitive Surgical's growth rests on da Vinci 5, Ion, SP and digital tools as recurring revenue rises and procedure risks persist.